Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac Amyloidosis

Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac Amyloidosis

Background: Sodium–glucose cotransporter 2 inhibitors (SGLT2i) have been found to have potential hematopoietic effects in patients with heart failure (HF). However, these benefits have not been studied in patients with cardiac amyloidosis (CA). CA patients present with HF symptoms...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikita Ermolaev, Robin Willixhofer, Christoph Krall, Christina Kronberger, René Rettl, Christina Binder, Franz Duca, Christian Nitsche, Andreas Kammerlander, Michael Poledniczek, Bernhard Gregshammer, Diana Ahmadi-Fazel, Mahshid Eslami, Luciana Camuz Ligios, Johannes Kastner, Jutta Bergler-Klein, Roza Badr Eslam
Format: Article
Language:English
Published: IMR Press 2025-03-01
Series:Reviews in Cardiovascular Medicine
Subjects:
amyloid cardiomyopathy
heart failure
sodium-glucose cotransporter 2 inhibitors
hematopoiesis
functional capacity
cardiopulmonary exercise testing
Online Access:https://www.imrpress.com/journal/RCM/26/3/10.31083/RCM26081
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.imrpress.com/journal/RCM/26/3/10.31083/RCM26081

Similar Items